Haemophilus b tetanus toxoid conjugate vaccine

On 1 register1 medicine1 company

Where it is registered

Each register with its number of medicines and a few of them.

Every register, a page at a time. Strengths and packs are on each medicine’s page.

8 results

Medicine	Register	Strength	Form	Status	Holder
MenhibrixCombination	United States	0.5ML	Injection	Withdrawn	GlaxoSmithKline Biologicals
VaxelisCombination	United States	0.5ML	Injection	Marketed	MSP Vaccine Company
VaxelisCombination	United States	0.5ML	Injection	Marketed	MSP Vaccine Company
Hiberix	United States	10UG/25UG	For Injection	Marketed	GlaxoSmithKline Biologicals
Acthib,Omnihib	United States	24UG	For Injection	Marketed	Sanofi Winthrop Industrie
PentacelCombination	United States	0.5ML	Injection	Marketed	Sanofi Vaccines Canada Ltd.
Pentaxim VaccineCombination	Singapore	min. 20 IU (30 Lf)/0.5 mL + 25 μg/0.5 mL + 25 μg/0.5 mL + 29 DU/0.5 mL + 7 DU/0.5 mL + 26 DU/0.5 mL + min. 40 IU (10 Lf) /0.5 mL + 10 μg/0.5 mL + 18 - 30 μg/0.5 mL	injection, powder, for suspension	Authorised	Sanofi-Aventis Singapore Pte. LTD.
Haemophilus B Conjugate Vaccine (Diphtheria Toxoid-Conjugate) Prohibit	Taiwan		注射劑	Cancelled	法台化學股份有限公司

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.